Table 2 Identification of differentially expressed lipids between non-stroke recurrence (non-SR) and stroke recurrence (SR) patients.

From: Lipidomic signature of stroke recurrence after transient ischemic attack

Features

m/z

Mass

RT (min)

p valuea

FDR

Regulation (SR vs. non-SR)

TG(56:1)

917.84994

916.8421

10.18423

2.05E-06

0.00031091

Down

TG(63:0)

1017.96584

1016.958

10.42379

0.00053035

0.040307

Down

TG(58:2)

960.91774

959.9099

10.18651

0.0020546

0.1041

Down

TG(50:5)b

842.74214

841.7343

9.549459

0.0038061

0.14463

Down

PE(P-18:0/18:2)b

728.58044

727.5726

7.76085

0.017047

0.51824

Down

DG(38:5)b

643.54474

642.5369

8.254209

0.041417

0.66839

Down

TG(53:7)

880.74514

879.7373

9.712666

0.043566

0.66839

Down

  1. RT, min Retention time expressed in minutes; FDR False discovery range, TG Triglyceride, DG Diglyceride, PE phosphoethanolamine.
  2. astudent t-test.
  3. bConfirmed by MS/MS spectra.
Back to article page